Trial | NCT01216033  Report issue

Title

Exploratory Study of Breast Cancer With ABY025
An Exploratory Study to Evaluate the Distribution of [111In]ABY-025 Uptake for SPECT Imaging in Subjects With Metastatic Breast Cancer

  • Phase

    Phase 1/Phase 2

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    7
The aim is to study if breast cancer metastases accumulate the newly developed HER2 binding molecule 111-In-ABY025 and if that shows whether the metastases express HER2.
Study Started
Oct 31
2010
Primary Completion
Jul 31
2011
Study Completion
Jul 31
2011
Last Update
Apr 15
2013
Estimate

Drug 111-In-ABY-025

Intravenous injection of the agent

Criteria 

Inclusion Criteria:

female age >20 years
one or more known metastases localizations

Exclusion Criteria:

other critical disease than breast cancer
age ≤ 20 years
No Results Posted